Literature DB >> 32331569

A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.

Mary C Moran1, Lisa A Beck2, Christopher T Richardson2.   

Abstract

Cytokines are key mediators of skin homeostasis and disease through their effects on keratinocytes, skin barrier integrity, immune activation, and microbial ecology. Sirobhushanam et al. (2020) suggest that the IFN signature in lupus erythematosus (LE) alters expression of epithelial barrier and adhesin genes, which, in turn, promotes Staphylococcus aureus colonization. This work highlights the need to better understand both barrier function and S. aureus colonization in LE, two new potential therapeutic targets for the treatment of LE.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID： 32331569      PMCID： PMC7384433          DOI： 10.1016/j.jid.2019.12.014

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  23 in total

Review 1.  Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.

Authors:  Jérôme C Martin; Dominique L Baeten; Régis Josien
Journal:  Clin Immunol       Date:  2014-05-23       Impact factor: 3.969

2.  Staphylococcus colonization of the skin and antimicrobial peptides.

Authors:  Michael Otto
Journal:  Expert Rev Dermatol       Date:  2010-04

3.  Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.

Authors:  Johann E Gudjonsson; J Michelle Kahlenberg; Mrinal K Sarkar; Grace A Hile; Lam C Tsoi; Xianying Xing; Jianhua Liu; Yun Liang; Celine C Berthier; William R Swindell; Matthew T Patrick; Shuai Shao; Pei-Suen Tsou; Ranjitha Uppala; Maria A Beamer; Anshika Srivastava; Stephanie L Bielas; Paul W Harms; Spiro Getsios; James T Elder; John J Voorhees
Journal:  Ann Rheum Dis       Date:  2018-07-18       Impact factor: 19.103

Review 4.  Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.

Authors:  Emma Guttman-Yassky; Kristine E Nograles; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2011-03-21       Impact factor: 10.793

5.  Epithelial barrier dysfunction in desmoglein-1 deficiency.

Authors:  Laura Polivka; Smail Hadj-Rabia; Elodie Bal; Stéphanie Leclerc-Mercier; Marine Madrange; Yamina Hamel; Damien Bonnet; Stéphanie Mallet; Hubert Lepidi; Caroline Ovaert; Patrick Barbet; Christophe Dupont; Bénédicte Neven; Arnold Munnich; Lisa M Godsel; Florence Campeotto; Robert Weil; Emmanuel Laplantine; Sylvie Marchetto; Jean-Paul Borg; William I Weis; Jean-Laurent Casanova; Anne Puel; Kathleen J Green; Christine Bodemer; Asma Smahi
Journal:  J Allergy Clin Immunol       Date:  2018-04-27       Impact factor: 10.793

6.  Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunction.

Authors:  Britta Hansmann; Kerstin Ahrens; Zhihong Wu; Ehrhardt Proksch; Ulf Meyer-Hoffert; Jens-Michael Schröder
Journal:  Exp Dermatol       Date:  2012-04       Impact factor: 3.960

7.  Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.

Authors:  Razvigor Darlenski; Evgeniya Hristakieva; Ufuk Aydin; Desisslava Gancheva; Tanya Gancheva; Antoaneta Zheleva; Veselina Gadjeva; Joachim W Fluhr
Journal:  J Dermatol Sci       Date:  2018-03-21       Impact factor: 4.563

8.  Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study.

Authors:  Ronald F van Vollenhoven; Bevra H Hahn; George C Tsokos; Carrie L Wagner; Peter Lipsky; Zahi Touma; Victoria P Werth; Robert M Gordon; Bei Zhou; Benjamin Hsu; Marc Chevrier; Manon Triebel; Jarrat L Jordan; Shawn Rose
Journal:  Lancet       Date:  2018-09-21       Impact factor: 79.321

9.  Staphylococcus aureus Colonization Is Increased on Lupus Skin Lesions and Is Promoted by IFN-Mediated Barrier Disruption.

Authors:  Sirisha Sirobhushanam; Navya Parsa; Tamra J Reed; Celine C Berthier; Mrinal K Sarkar; Grace A Hile; Lam C Tsoi; Josh Banfield; Craig Dobry; Alexander R Horswill; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  J Invest Dermatol       Date:  2019-12-23       Impact factor: 8.551

10.  Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.

Authors:  Matthew G Brewer; Takeshi Yoshida; Fiona I Kuo; Sade Fridy; Lisa A Beck; Anna De Benedetto
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.